UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.640

Sortiert nach

Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells

Cancer research (Chicago, Ill.), 2009-08, Vol.69 (16), p.6704-6712

2009

Link zum Volltext

Verfügbarkeit prüfen

Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2

Cancer research (Chicago, Ill.), 2008-10, Vol.68 (19), p.7905-7914

2008

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma

Cancer research (Chicago, Ill.), 2010-02, Vol.70 (3), p.1063-1071

2010

Link zum Volltext

Verfügbarkeit prüfen

Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL

Cancer research (Chicago, Ill.), 2009-09, Vol.69 (17), p.6871-6878

2009

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (13), p.5246-5256

2008

Link zum Volltext

Verfügbarkeit prüfen

Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells

British journal of cancer, 2013-11, Vol.109 (10), p.2587-2596

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K PTEN Akt mTOR pathway

Leukemia, 2011-07, Vol.25 (7), p.1064-1079

2011

Link zum Volltext

Verfügbarkeit prüfen

RNAi-Mediated Silencing of Nuclear Factor Erythroid-2-Related Factor 2 Gene Expression in Non-Small Cell Lung Cancer Inhibits Tumor Growth and Increases Efficacy of Chemotherapy

Cancer research (Chicago, Ill.), 2008-10, Vol.68 (19), p.7975-7984

2008

Link zum Volltext

Verfügbarkeit prüfen

Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer

Clinical cancer research, 2010-11, Vol.16 (22), p.5489-5498

2010

Link zum Volltext

Verfügbarkeit prüfen

Cancer Stem Cells and Chemosensitivity

Clinical cancer research, 2011-08, Vol.17 (15), p.4942-4947

2011

Link zum Volltext

Verfügbarkeit prüfen

Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1

International journal of cancer, 2012-04, Vol.130 (8), p.1787-1797

2012

Link zum Volltext

Verfügbarkeit prüfen

Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma

British journal of cancer, 2011-02, Vol.104 (4), p.707-713

2011

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3

Clinical cancer research, 2010-11, Vol.16 (21), p.5189-5199

2010

Link zum Volltext

Verfügbarkeit prüfen

Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models

Clinical cancer research, 2013, Vol.19 (1), p.138-147

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies

Cancer research (Chicago, Ill.), 2011-02, Vol.71 (4), p.1362-1373

2011

Link zum Volltext

Verfügbarkeit prüfen

Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer

Clinical cancer research, 2012-10, Vol.18 (19), p.5399-5411

2012

Link zum Volltext

Verfügbarkeit prüfen

Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial–mesenchymal transition and chemoresistance in biliary tract cancer

European journal of cancer (1990), 2013-05, Vol.49 (7), p.1725-1740

2013

Link zum Volltext

Verfügbarkeit prüfen

GDNF―RET Signaling in ER-Positive Breast Cancers Is a Key Determinant of Response and Resistance to Aromatase Inhibitors

Cancer research (Chicago, Ill.), 2013-06, Vol.73 (12), p.3783-3795

2013

Link zum Volltext

Verfügbarkeit prüfen

mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Clinical cancer research, 2009-09, Vol.15 (17), p.5404-5413

2009

Link zum Volltext

Verfügbarkeit prüfen

Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation

Clinical cancer research, 2005-06, Vol.11 (11), p.4182-4190

2005

Link zum Volltext

Verfügbarkeit prüfen

Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3219-3225

2013

Link zum Volltext

Verfügbarkeit prüfen

New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors

Clinical cancer research, 2010-05, Vol.16 (9), p.2489-2495

2010

Link zum Volltext

Verfügbarkeit prüfen

Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress

Angiogenesis (London), 2011-09, Vol.14 (3), p.293-307

2011

Link zum Volltext

Verfügbarkeit prüfen

The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3

Cancer research (Chicago, Ill.), 2010-02, Vol.70 (4), p.1573-1584

2010

Link zum Volltext

Verfügbarkeit prüfen

Progesterone Receptor Signaling in the Microenvironment of Endometrial Cancer Influences Its Response to Hormonal Therapy

Cancer research (Chicago, Ill.), 2013-08, Vol.73 (15), p.4697-4710

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.640

Suche als RSS-Feed

Aktive Filter

ThemaDrug Resistance

ThemaCancer Research

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.600)
Mit Volltextzugriff
(1.623)

Publikationsform

Artikel
(1.636)
Bücher
(4)

Sprache

Englisch
(1.640)
Japanisch
(1.415)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(1.636)
Oncology
(1.634)
Life Sciences & Biomedicine
(1.592)
Science & Technology
(1.592)
Humans
(1.577)
Tumors
(1.136)
Pharmacology. Drug Treatments
(1.131)
Antineoplastic Agents
(1.107)
Drug Resistance, Neoplasm
(920)
Female
(702)
Cell Line, Tumor
(627)
Animals
(506)
Antineoplastic Agents - Pharmacology
(427)
Mice
(388)
Male
(385)
Middle Aged
(363)
Drug Resistance, Neoplasm - Genetics
(320)
Aged
(308)

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(335)
Clinical Cancer Research
(256)
Cancer Chemotherapy And Pharmacology
(231)
International Journal Of Cancer
(136)
British Journal Of Cancer
(98)
Journal Of Clinical Oncology
(95)
Cancer Science
(67)
Journal Of Cancer Research And Clinical Oncology
(51)
Leukemia
(39)
Lung Cancer
(34)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells

Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2

Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma

Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL

Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma

Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells

Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K PTEN Akt mTOR pathway

RNAi-Mediated Silencing of Nuclear Factor Erythroid-2-Related Factor 2 Gene Expression in Non-Small Cell Lung Cancer Inhibits Tumor Growth and Increases Efficacy of Chemotherapy

Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer

Cancer Stem Cells and Chemosensitivity

Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1

Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma

Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3

Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models

Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies

Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer

Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial–mesenchymal transition and chemoresistance in biliary tract cancer

GDNF―RET Signaling in ER-Positive Breast Cancers Is a Key Determinant of Response and Resistance to Aromatase Inhibitors

mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation

Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial

New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors

Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress

The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3

Progesterone Receptor Signaling in the Microenvironment of Endometrial Cancer Influences Its Response to Hormonal Therapy

Aktive Filter

Suchergebnisse filtern